Bioscan, Inc.

Bioscan is one of the industry’s leading developers of advanced instrumentation for the synthesis and detection of radiolabeled compounds used in life science research, pharmaceutical development, and nuclear medicine. Its team of scientists and engineers designs, produces, and services equipment which produces radiopharmaceuticals, performs quality control procedures, and measures the results of key in vivo and in vitro experiments using a wide range of radioisotopes.

Positron Emission tomography (PET) is one of the fastest-growing areas of research and clinical practice. Bioscan provides key equipment for the commercial production of FDG, the main radiopharmaceutical used in the clinical practice of PET.

Bioscan also provides key radiochromatography detection equipment used in the production of radiopharmaceuticals and in the development of key radiolabeled compounds for life science and pharmaceutical research.